Impressive Vertex hepatitis C drug data unveiled
November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.
Nine-month-old baby may have been cured of HIV, U.S. scientists say
March 6, 2014 — BOSTON (Reuters) - A 9-month-old baby who was born in
California with the HIV virus that leads to AIDS may have been
cured as a result of treatments that doctors began just four
hours after her birth, medical researchers said on Wednesday.
Energy drinks linked to risky behaviors among teens
March 5, 2014 — NEW YORK (Reuters Health) - Consuming highly caffeinated
energy drinks like Amp, Red Bull or Rockstar could be a telltale
sign of other problems for high school students, a Canadian
Insurers, Medicaid fear multibillion-dollar hepatitis C drug tab
March 5, 2014 — (Reuters) - U.S. health insurers are seeking help from state
health officials to foot the bill for a new generation of
hepatitis C treatments that could cost the nation $200 billion
or more in the next five years.
Select news items provided by Reuters Health